TOKYOMEDIJAPAN MEDICAL REFERENCE
⌕ Search databaseOfficial source · PMDA / MHLW
Rx · Reference only · no online purchase

Norvasc (Amlodipine)

Norvasc / Amlodipine. Mainly used for high blood pressure and angina. This page uses a representative Japanese product as the reference entry; other products or dosage forms may exist for the same ingredient.

PMDAproduct-level source2026-05label updated2026-10-05site verified
ノルバスク錠2.5mg/5mg/10mg・ノルバスクOD錠2.5mg/5mg/10mg · 5 mg
Japanese product photo · 5 mg · PETMEDIC PRO
Main useMainly used for high blood pressure and angina.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
Japan product name
ノルバスク錠2.5mg/5mg/10mg・ノルバスクOD錠2.5mg/5mg/10mg
Brand
Norvasc
Generic name
Amlodipine
Japanese generic name
アムロジピン
Chinese name
氨氯地平
Marketing authorization holder
ヴィアトリス製薬合同会社
Strengths
2.5 mg / 5 mg / 10 mg
Dosage form
tablet / OD tablet
Therapeutic area
Cardiovascular
Regulatory status
Rx
Label updated
2026-05
TOKYO MEDI verified
2026-10-05
MEDICINE REFERENCE

Detailed product reference

Summaries refer to the listed Japanese product. Eligibility, adjustments and full risks depend on its label and strength; a clinician determines individual treatment.

01

Product overview

A long-acting dihydropyridine calcium-channel blocker. Norvasc conventional and orally disintegrating tablets contain the same active ingredient; administration and packaging differ.

Read source section ↗
02

Mechanism of action

Blocks voltage-dependent calcium entry in vascular smooth muscle, relaxing coronary and peripheral vessels.

Read source section ↗
03

Japanese indications & eligibility

Japanese indications are hypertension and angina. Pediatric hypertension provisions cover children aged six and over.

Read source section ↗
04

Administration & dose differences

Label examples: hypertension 2.5–5 mg once daily, up to 10 mg when needed; angina usually 5 mg daily.

Read source section ↗
05

Adverse effects & key risks

Edema, flushing, headache and dizziness may occur. Important risks include excessive hypotension and liver or blood abnormalities.

Read source section ↗
06

Contraindications & special populations

Contraindicated with ingredient hypersensitivity. Liver impairment, low blood pressure and pregnancy require assessment.

Read source section ↗
07

Drug interactions

Review CYP3A4 modifiers, other antihypertensives, simvastatin and tacrolimus.

Read source section ↗
08

Assessment & monitoring

Track blood pressure, pulse, edema and dizziness; assess laboratory findings when indicated.

Read source section ↗
09

Storage & handling

Store at room temperature in the original packaging. The photo shows a 5 mg blister only.

Read source section ↗
10

Sources & verification

Product checked ·

Official source

These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.